Search

Your search keyword '"Slipek, Nicholas J."' showing total 25 results

Search Constraints

Start Over You searched for: Author "Slipek, Nicholas J." Remove constraint Author: "Slipek, Nicholas J."
25 results on '"Slipek, Nicholas J."'

Search Results

3. Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

4. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

5. PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma

6. CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

7. Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair

12. Supplementary Data from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

13. Data from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

14. Table S2 from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

15. A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes

17. Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

18. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade

19. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

20. Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

23. Engineering Memory T Cells as a platform for Long-Term Enzyme Replacement Therapy in Lysosomal Storage Disorders.

24. Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.

25. CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits.

Catalog

Books, media, physical & digital resources